Myocardial oedema : pathophysiological basis and implications for the failing heart
© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology..
Myocardial fluid homeostasis relies on a complex interplay between microvascular filtration, interstitial hydration, cardiomyocyte water uptake and lymphatic removal. Dysregulation of one or more of these mechanisms may result in myocardial oedema. Interstitial and intracellular fluid accumulation disrupts myocardial architecture, intercellular communication, and metabolic pathways, decreasing contractility and increasing myocardial stiffness. The widespread use of cardiac magnetic resonance enabled the identification of myocardial oedema as a clinically relevant imaging finding with prognostic implications in several types of heart failure. Furthermore, growing experimental evidence has contributed to a better understanding of the physical and molecular interactions in the microvascular barrier, myocardial interstitium and lymphatics and how they might be disrupted in heart failure. In this review, we summarize current knowledge on the factors controlling myocardial water balance in the healthy and failing heart and pinpoint the new potential therapeutic avenues.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
ESC heart failure - 9(2022), 2 vom: 19. Apr., Seite 958-976 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vasques-Nóvoa, Francisco [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiac lymphatics |
---|
Anmerkungen: |
Date Completed 25.03.2022 Date Revised 25.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1002/ehf2.13775 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336822243 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336822243 | ||
003 | DE-627 | ||
005 | 20231225233020.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ehf2.13775 |2 doi | |
028 | 5 | 2 | |a pubmed24n1122.xml |
035 | |a (DE-627)NLM336822243 | ||
035 | |a (NLM)35150087 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vasques-Nóvoa, Francisco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Myocardial oedema |b pathophysiological basis and implications for the failing heart |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2022 | ||
500 | |a Date Revised 25.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. | ||
520 | |a Myocardial fluid homeostasis relies on a complex interplay between microvascular filtration, interstitial hydration, cardiomyocyte water uptake and lymphatic removal. Dysregulation of one or more of these mechanisms may result in myocardial oedema. Interstitial and intracellular fluid accumulation disrupts myocardial architecture, intercellular communication, and metabolic pathways, decreasing contractility and increasing myocardial stiffness. The widespread use of cardiac magnetic resonance enabled the identification of myocardial oedema as a clinically relevant imaging finding with prognostic implications in several types of heart failure. Furthermore, growing experimental evidence has contributed to a better understanding of the physical and molecular interactions in the microvascular barrier, myocardial interstitium and lymphatics and how they might be disrupted in heart failure. In this review, we summarize current knowledge on the factors controlling myocardial water balance in the healthy and failing heart and pinpoint the new potential therapeutic avenues | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Cardiac lymphatics | |
650 | 4 | |a Cardiac microcirculation | |
650 | 4 | |a Cardiac pericytes | |
650 | 4 | |a Extracellular matrix | |
650 | 4 | |a Heart failure | |
650 | 4 | |a Myocardial interstitium | |
650 | 4 | |a Myocardial oedema | |
700 | 1 | |a Angélico-Gonçalves, António |e verfasserin |4 aut | |
700 | 1 | |a Alvarenga, José M G |e verfasserin |4 aut | |
700 | 1 | |a Nobrega, João |e verfasserin |4 aut | |
700 | 1 | |a Cerqueira, Rui J |e verfasserin |4 aut | |
700 | 1 | |a Mancio, Jennifer |e verfasserin |4 aut | |
700 | 1 | |a Leite-Moreira, Adelino F |e verfasserin |4 aut | |
700 | 1 | |a Roncon-Albuquerque, Roberto |c Jr |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ESC heart failure |d 2014 |g 9(2022), 2 vom: 19. Apr., Seite 958-976 |w (DE-627)NLM261791397 |x 2055-5822 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2022 |g number:2 |g day:19 |g month:04 |g pages:958-976 |
856 | 4 | 0 | |u http://dx.doi.org/10.1002/ehf2.13775 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2022 |e 2 |b 19 |c 04 |h 958-976 |